Broom Colin MD 4
4 · Nabriva Therapeutics plc · Filed Aug 1, 2019
Insider Transaction Report
Form 4
Broom Colin MD
Chief Executive Officer
Transactions
- Award
Stock Option
2019-07-31+35,000→ 35,000 totalExp: 2029-07-31→ Ordinary Shares (35,000 underlying)
Footnotes (2)
- [F1]The exercise price is $2.38 per share.
- [F2]This option was granted on July 31, 2019. One hundred percent (100%) of the option will vest on July 31, 2020, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.